Pakistan will host its first Pak-China Pharmaceutical and Healthcare Investment Conference from July 16 to 19 in Karachi as the country seeks to attract greater Chinese investment into healthcare and pharmaceutical industries.
Strong Participation Expected
According to conference preparations, more than 50 companies have already registered through the official platform. Meanwhile, organizers have prepared several bankable investment projects for presentation to potential investors.
Focus on Healthcare and Industrial Cooperation
In addition, leading Chinese pharmaceutical companies, medical equipment manufacturers, and healthcare firms are expected to attend. The event will therefore serve as a platform to expand industrial cooperation and investment partnerships.
Priority Areas for Investment
The conference will highlight several strategic sectors, including active pharmaceutical ingredients (APIs), vaccines, biologics, medical devices, clinical research, and related pharmaceutical manufacturing industries.
Goal to Build Industrial Capacity
Officials say the initiative supports broader efforts to modernize Pakistan’s healthcare ecosystem. Moreover, the conference aims to encourage joint ventures and convert investment discussions into long-term industrial development.
Expanding Pakistan–China Economic Engagement
Overall, the event reflects growing economic cooperation between Pakistan and China. As a result, policymakers expect stronger investment flows and increased capacity across the pharmaceutical and healthcare sectors.
